Report cover image

Acobiom - Product Pipeline Analysis, 2022 Update

Publisher GlobalData
Published Feb 07, 2023
Length 39 Pages
SKU # GBDT17776230

Description

Summary

Acobiom (Acobiom) is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA and DNA biomarkers, which finds application in the areas of disease detection, and classification, patient stratification, companion diagnosis and disease prognosis. It develops diagnostics centered on personalized medicine and precision medicine applications. Acobiom also provides services such as sequencing, next generation sequencing (NGS), bioinformatics, biostatistics, real time PCR, and others. The company offers technology platforms such as qRT-PCR, gene expression and bioinformatics. The company provides products in the areas of personalized medicines, medical products, leukemia and gemcitest, among others. Acobiom is headquartered in Montpellier, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Acobiom
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

39 Pages
Acobiom Company Overview
Acobiom Company Snapshot
Acobiom Pipeline Products and Ongoing Clinical Trials Overview
Acobiom – Pipeline Analysis Overview
Acobiom - Key Facts
Acobiom - Major Products and Services
Acobiom Pipeline Products by Development Stage
Acobiom Pipeline Products Overview
Biomarker Test - Hantavirus
Biomarker Test - Hantavirus Product Overview
Companion Diagnostic Assay - Masitinib
Companion Diagnostic Assay - Masitinib Product Overview
Companion Diagnostic Assay - Prostate Cancer
Companion Diagnostic Assay - Prostate Cancer Product Overview
Companion Diagnostic Test - Alzheimer's Disease
Companion Diagnostic Test - Alzheimer's Disease Product Overview
Companion Diagnostic Test - Breast Cancer
Companion Diagnostic Test - Breast Cancer Product Overview
Companion Diagnostic Test - Lung Cancer
Companion Diagnostic Test - Lung Cancer Product Overview
Companion Diagnostic Test - Triple Negative Breast Cancer
Companion Diagnostic Test - Triple Negative Breast Cancer Product Overview
Dental Device
Dental Device Product Overview
Diagnostic Assay - Chronic Myelomonocytic Leukemia
Diagnostic Assay - Chronic Myelomonocytic Leukemia Product Overview
Diagnostic Test - Dengue
Diagnostic Test - Dengue Product Overview
Diagnostic Test - Leishmania
Diagnostic Test - Leishmania Product Overview
Diagnostic Tool - Left Ventricular Heart Failure
Diagnostic Tool - Left Ventricular Heart Failure Product Overview
Diagnostic/Prognostic Assay - Alzheimer's Disease
Diagnostic/Prognostic Assay - Alzheimer's Disease Product Overview
Diagnostic/Prognostic Assay - Breast Cancer
Diagnostic/Prognostic Assay - Breast Cancer Product Overview
Diagnostic/Prognostic Assay - Lung Cancer
Diagnostic/Prognostic Assay - Lung Cancer Product Overview
Diagnostic/Prognostic Assay - Pancreatic Cancer
Diagnostic/Prognostic Assay - Pancreatic Cancer Product Overview
Screening Device - Bipolar Disorder
Screening Device - Bipolar Disorder Product Overview
Acobiom - Key Competitors
Acobiom - Key Employees
Acobiom - Locations And Subsidiaries
Head Office
Recent Developments
Acobiom, Recent Developments
Oct 21, 2021: A 20-year expertise in omics services and pharmacogenomics analysis
Nov 21, 2019: Acobiom announces the CE marking of GemciTest
Nov 03, 2012: Skuldtech And AB Science Announce Identification Of New Predictive Markers For Pancreatic Cancer Survival Associated With Masitinib Treatment
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Acobiom Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Acobiom Pipeline Products by Equipment Type
Table 3: Acobiom Pipeline Products by Indication
Table 4: Acobiom, Key Facts
Table 5: Acobiom, Major Products and Services
Table 6: Acobiom Number of Pipeline Products by Development Stage
Table 7: Acobiom Pipeline Products Summary by Development Stage
Table 8: Biomarker Test - Hantavirus - Product Status
Table 9: Biomarker Test - Hantavirus - Product Description
Table 10: Companion Diagnostic Assay - Masitinib - Product Status
Table 11: Companion Diagnostic Assay - Masitinib - Product Description
Table 12: Companion Diagnostic Assay - Prostate Cancer - Product Status
Table 13: Companion Diagnostic Assay - Prostate Cancer - Product Description
Table 14: Companion Diagnostic Test - Alzheimer's Disease - Product Status
Table 15: Companion Diagnostic Test - Alzheimer's Disease - Product Description
Table 16: Companion Diagnostic Test - Breast Cancer - Product Status
Table 17: Companion Diagnostic Test - Breast Cancer - Product Description
Table 18: Companion Diagnostic Test - Lung Cancer - Product Status
Table 19: Companion Diagnostic Test - Lung Cancer - Product Description
Table 20: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status
Table 21: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description
Table 22: Dental Device - Product Status
Table 23: Dental Device - Product Description
Table 24: Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Status
Table 25: Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Description
Table 26: Diagnostic Test - Dengue - Product Status
Table 27: Diagnostic Test - Dengue - Product Description
Table 28: Diagnostic Test - Leishmania - Product Status
Table 29: Diagnostic Test - Leishmania - Product Description
Table 30: Diagnostic Tool - Left Ventricular Heart Failure - Product Status
Table 31: Diagnostic Tool - Left Ventricular Heart Failure - Product Description
Table 32: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Status
Table 33: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Description
Table 34: Diagnostic/Prognostic Assay - Breast Cancer - Product Status
Table 35: Diagnostic/Prognostic Assay - Breast Cancer - Product Description
Table 36: Diagnostic/Prognostic Assay - Lung Cancer - Product Status
Table 37: Diagnostic/Prognostic Assay - Lung Cancer - Product Description
Table 38: Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Status
Table 39: Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Description
Table 40: Screening Device - Bipolar Disorder - Product Status
Table 41: Screening Device - Bipolar Disorder - Product Description
Table 42: Acobiom, Key Employees
Table 43: Glossary
List of Figures
Figure 1: Acobiom Pipeline Products by Equipment Type
Figure 2: Acobiom Pipeline Products by Development Stage

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us